Comments
Loading...

Predictive Oncology

POAINASDAQ
Logo brought to you by Benzinga Data
$0.720000
0.034.50%
At close: -
$0.700300
-0.02-2.74%
After Hours: 5:26 PM EDT

Predictive Oncology (NASDAQ:POAI) Stock, Analyst Ratings, Price Targets, Forecasts

Predictive Oncology Inc has a consensus price target of - based on the ratings of 1 analysts. The high is issued by on . The low is issued by on . The 1 most-recent analyst ratings were released by HC Wainwright & Co. on August 19, 2024, respectively. With an average price target of $3 between HC Wainwright & Co., there's an implied 328.39% upside for Predictive Oncology Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Aug
1
Nov
Buy
Hold
Sell
Strong Sell

Analyst Ratings for Predictive Oncology

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Predictive Oncology (POAI) stock?

A

The latest price target for Predictive Oncology (NASDAQ:POAI) was reported by HC Wainwright & Co. on November 15, 2024. The analyst firm set a price target for $0.00 expecting POAI to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Predictive Oncology (POAI)?

A

The latest analyst rating for Predictive Oncology (NASDAQ:POAI) was provided by HC Wainwright & Co., and Predictive Oncology downgraded their neutral rating.

Q

When was the last upgrade for Predictive Oncology (POAI)?

A

There is no last upgrade for Predictive Oncology

Q

When was the last downgrade for Predictive Oncology (POAI)?

A

The last downgrade for Predictive Oncology Inc happened on November 15, 2024 when HC Wainwright & Co. changed their price target from N/A to N/A for Predictive Oncology Inc.

Q

When is the next analyst rating going to be posted or updated for Predictive Oncology (POAI)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Predictive Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Predictive Oncology was filed on November 15, 2024 so you should expect the next rating to be made available sometime around November 15, 2025.

Q

Is the Analyst Rating Predictive Oncology (POAI) correct?

A

While ratings are subjective and will change, the latest Predictive Oncology (POAI) rating was a downgraded with a price target of $0.00 to $0.00. The current price Predictive Oncology (POAI) is trading at is $0.70, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch